• PTX3 Regulates TLR4/NF-κB/FGF21 Axis in Glucocorticoid-Induc

  2026-07-01

  Li et al. identify a protective role for pentraxin 3 (PTX3) in glucocorticoid-induced osteonecrosis of the femoral head (ONFH) via the TLR4/NF-κB/FGF21 axis. Their findings provide mechanistic insight into bone preservation strategies and highlight the significance of targeting PKC/NF-κB-mediated signaling in osteoclastogenesis research.

• CKI 7 dihydrochloride: Selective Casein Kinase 1 Inhibitor f

  2026-06-30

  CKI 7 dihydrochloride is a potent and selective Casein kinase 1 inhibitor, widely applied in studies of Wnt signaling and circadian rhythm regulation. Its validated biochemical properties and specificity enable precise dissection of phosphorylation pathways in cancer and cell biology research.

• Pharmacokinetics of Corydalis saxicola Alkaloids in MASH Mod

  2026-06-30

  This study systematically investigates how metabolic dysfunction-associated steatohepatitis (MASH) alters the pharmacokinetics and tissue distribution of Corydalis saxicola Bunting total alkaloids in mice. Findings reveal the critical role of disease-driven changes in drug metabolism and transporter expression, informing rational dosing strategies for MASLD/MASH therapies.

• Astrocytic GAT-3 Controls Synaptic Transmission in Dentate G

  2026-06-29

  This study reveals that astrocytic GAT-3 is essential for modulating synaptic transmission and memory formation in the dentate gyrus. By dissecting how astrocyte-driven GABA uptake and calcium signaling influence excitatory neurotransmission, the research uncovers mechanisms with implications for understanding cognitive processes and potential therapeutic targets.

• PR-619 Workflow Guide: Protocols and Troubleshooting

  2026-06-29

  PR-619 is a broad-spectrum, reversible deubiquitylating enzymes inhibitor specifically suited for cell-based studies of the ubiquitination pathway. It is most appropriate when broad DUB inhibition is desired without direct proteasome interference. This compound should not be used for selective DUB studies or as a proteasome inhibitor substitute.

• Leveraging Diethylmaleate for Redox & Resistance Research Br

  2026-06-28

  This article explores how Diethylmaleate—a gold-standard oxidative stress research chemical—empowers translational scientists to probe glutathione S-transferase (GST) function, redox regulation, and resistance mechanisms in insect and mammalian models. By synthesizing mechanistic insights and offering actionable guidance, it charts a path for researchers to design robust oxidative stress assays, optimize toxicology workflows, and translate bench discoveries into actionable solutions for both agriculture and biomedicine.

• BRD4770: Redefining Epigenetic Control in Cancer Biology Res

  2026-06-27

  Discover how BRD4770, a G9a histone methyltransferase inhibitor, enables precise modulation of histone H3K9 methylation and cellular senescence. This article offers a unique, technical perspective on BRD4770's impact on cancer biology research and advanced assay design.

• FH1 Small Molecule (B3700): Precision Maturation for iHeps i

  2026-06-26

  Explore how FH1 small molecule (B3700) uniquely enables precise, functional maturation of iPS cell-derived hepatocytes for advanced liver research. Uncover mechanistic insights, practical protocols, and why this compound is pivotal for next-gen gene and cell therapy innovation.

• SNAI1–PIK3R2/p-EphA2 Axis Drives EMT and Stemness in TETs

  2026-06-26

  This study identifies SNAI1 as a central regulator of epithelial-mesenchymal transition (EMT) and cancer stem cell-like properties in thymic epithelial tumors (TETs), acting through the PIK3R2/p-EphA2 signaling axis. The findings illuminate actionable molecular mechanisms underlying TET progression and suggest new therapeutic targets for these rare malignancies.

• Sitagliptin Phosphate Monohydrate: DPP-4 Inhibitor in Metabo

  2026-06-25

  Sitagliptin phosphate monohydrate offers researchers precision and reproducibility in DPP-4 inhibition, making it indispensable for dissecting incretin hormone pathways and metabolic disease mechanisms. This article details practical assay workflows, troubleshooting guidance, and insights from cutting-edge research to optimize experimental outcomes.

• (Z)-4-Hydroxytamoxifen: Applied Workflows in Estrogen Recept

  2026-06-25

  (Z)-4-Hydroxytamoxifen delivers unrivaled selectivity and potency for dissecting estrogen receptor pathways in preclinical research. This article decodes advanced protocols, explores troubleshooting strategies, and connects the latest scientific innovations to real-world assay design—empowering researchers to accelerate discoveries in endocrine and breast cancer biology.

• Verbascoside in PKC/NF-κB Inhibition: Expanding from Bone to

  2026-06-24

  Explore how Verbascoside, a potent PKC/NF-κB inhibitor, advances both osteoclastogenesis research and emerging neuroinflammatory models by integrating the latest mechanistic evidence. This article uniquely bridges cellular signaling, reference study insights, and experimental design considerations.

• BODIPY 581/591 C11: Ratiometric Fluorescent Probe for Lipid

  2026-06-23

  BODIPY 581/591 C11 is a ratiometric fluorescent probe enabling real-time, quantitative lipid peroxidation detection in live cells and membranes. Its red-to-green fluorescence shift upon oxidation allows precise oxidative stress measurement and antioxidant capacity evaluation. This probe is validated for specificity, photostability, and workflow integration in biomedical research.

• Disodium Bicinchoninate: Catalyzing Cardiac Fibrosis Researc

  2026-06-23

  This thought-leadership article explores how disodium bicinchoninate (sodium [2,2'-biquinoline]-4,4'-dicarboxylate), a high-purity, water-soluble small molecule biochemical reagent from APExBIO, empowers translational researchers to unlock new pathways in diabetic myocardial fibrosis research. By synthesizing mechanistic insights from recent cGMP/PKG pathway studies and benchmarking assay optimization strategies, we provide actionable guidance for leveraging advanced molecular biology reagents to accelerate discovery and innovation in cardiovascular disease models.

• Thymoquinone Counters Doxorubicin Cardiotoxicity via Nrf2/HO

  2026-06-22

  This study demonstrates that thymoquinone, a bioactive quinone, protects murine hearts from doxorubicin-induced cardiotoxicity by activating the Nrf2/HO-1 pathway and suppressing ferroptosis. The findings establish a mechanistic foundation for using thymoquinone in preclinical models targeting oxidative and iron-mediated cardiac injury.

15361 records 4/1025 page Previous Next 12345 下5页 Last page